Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Development of novel vaccines using DNA shuffling and screening strategies.

Locher CP, Soong NW, Whalen RG, Punnonen J.

Curr Opin Mol Ther. 2004 Feb;6(1):34-9. Review.

PMID:
15011779
2.

Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies.

Locher CP, Heinrichs V, Apt D, Whalen RG.

Expert Opin Biol Ther. 2004 Apr;4(4):589-97. Review.

PMID:
15102607
3.

Easy approach to DNA shuffling: its potential implication in health sciences.

Pokhrel S, Lamsal M, Wang ZX.

Nepal Med Coll J. 2006 Jun;8(2):136-9.

PMID:
17017407
4.

DNA shuffling and vaccines.

Whalen RG, Kaiwar R, Soong NW, Punnonen J.

Curr Opin Mol Ther. 2001 Feb;3(1):31-6. Review.

PMID:
11249729
5.

Directed evolution of extradiol dioxygenase by a novel in vivo DNA shuffling.

Xu S, Ju J, Misono H, Ohnishi K.

Gene. 2006 Mar 1;368:126-37. Epub 2006 Jan 23.

PMID:
16434152
6.

A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.

Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K.

Virology. 2006 Sep 15;353(1):166-73. Epub 2006 Jun 30.

7.

Recent progress in biomolecular engineering.

Ryu DD, Nam DH.

Biotechnol Prog. 2000 Jan-Feb;16(1):2-16. Review.

PMID:
10662483
8.

Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.

Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J.

Vaccine. 2006 Jan 16;24(3):335-44. Epub 2005 Aug 10.

PMID:
16125280
9.

DNA shuffling and screening strategies for improving vaccine efficacy.

Locher CP, Paidhungat M, Whalen RG, Punnonen J.

DNA Cell Biol. 2005 Apr;24(4):256-63. Review.

PMID:
15812242
10.

Applications of DNA shuffling to pharmaceuticals and vaccines.

Patten PA, Howard RJ, Stemmer WP.

Curr Opin Biotechnol. 1997 Dec;8(6):724-33. Review.

PMID:
9425664
11.

The impact of new technologies on vaccine development.

Winther MD, Dougan G.

Biotechnol Genet Eng Rev. 1984;2:1-39. Review.

PMID:
6085856
12.

New strategies for immune-mediated anti-viral drug and vaccine development.

Chen CC, Ron Y.

Curr Pharm Des. 2006;12(11):1391-401. Review.

PMID:
16611123
13.

Combinatorial protein design by in vitro recombination.

Giver L, Arnold FH.

Curr Opin Chem Biol. 1998 Jun;2(3):335-8. Review.

PMID:
9691067
14.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
15.

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.

Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS.

Vaccine. 2009 Jun 24;27(31):4152-60. doi: 10.1016/j.vaccine.2009.04.049. Epub 2009 May 9.

PMID:
19406186
16.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
17.

An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.

Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM.

Vaccine. 2006 Apr 5;24(15):2880-93. Epub 2006 Jan 19.

PMID:
16472545
18.

Salmonella-based vaccines for infectious diseases.

Kwon YM, Cox MM, Calhoun LN.

Expert Rev Vaccines. 2007 Apr;6(2):147-52. Review.

PMID:
17408365
19.

Molecular breeding of viruses.

Soong NW, Nomura L, Pekrun K, Reed M, Sheppard L, Dawes G, Stemmer WP.

Nat Genet. 2000 Aug;25(4):436-9.

PMID:
10932190
20.

Diverse plasmid DNA vectors by directed molecular evolution of cytomegalovirus promoters.

Wright A, Semyonov A, Dawes G, Crameri A, Lyons R, Stemmer WP, Apt D, Punnonen J.

Hum Gene Ther. 2005 Jul;16(7):881-92.

PMID:
16000069

Supplemental Content

Support Center